Literature DB >> 4138924

Analyses of lymphocytes from patients with rheumatoid arthritis and systemic lupus erythematosus. Occurrence of interfering cold-reactive antilymphocyte antibodies.

R J Winchester, J B Winfield, F Siegal, P Wernet, Z Bentwich, H G Kunkel.   

Abstract

Large percentages of the lymphocytes from some patients with rheumatoid arthritis and systemic lupus erythematosus were densely covered with Ig demonstrable by immunofluorescence, which was occasionally present in the form of caps. The amount and character of the Ig staining depended largely on the procedures used in the isolation and washing of the lymphocytes. Cold-reactive antilymphocyte antibodies present in many sera wre primarily responsible for these variations. Overnight culture of the lymphocytes proved to be an efficient procedure for the removal of adsorbed antibody. Some evidence was also obtained for the presence of circulating immune complexes and exogenous rheumatoid factor molecules on the lymphocyte surface. Thus on freshly isolated cells the demonstration of surface Ig proved to an unreliable marker of bone marrow-derived (B) cells in these disease: the actual percent of B cells with intrinsic surface Ig was often markedly decreased. In patients with systemic lupus erythematosus, this reduction was in agreement with the low numbers of cells that had a receptor for aggregated IgG. The mean percentage of thymus-derived (T) cells in both diseases was slightly greater than the normal level.The concentrations of lymphocytes in joint fluids from patients with rheumatoid arthritis were often greater than levels found in blood. T cells primarily accounted for this increase. The T cells typically formed unusually dense rosettes with sheep erythrocytes. B lymphocytes were proportionally much diminished. Evidence was obtained for the existence of a major joint fluid lymphocyte population that lacked all assayed surface markers.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4138924      PMCID: PMC301656          DOI: 10.1172/JCI107852

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  Human lymphocyte subpopulations. Effect of corticosteroids.

Authors:  D T Yu; P J Clements; H E Paulus; J B Peter; J Levy; E V Barnett
Journal:  J Clin Invest       Date:  1974-02       Impact factor: 14.808

2.  Immunoglobulin and receptors for C3 on lymphocytes from patients with rheumatoid arthritis.

Authors:  O J Mellbye; R P Messner; J R DeBord; R C Williams
Journal:  Arthritis Rheum       Date:  1972 Jul-Aug

3.  Immunoglobulins on the surface of human lymphocytes.

Authors:  M Papamichail; J C Brown; E J Holborow
Journal:  Lancet       Date:  1971-10-16       Impact factor: 79.321

4.  Lymphocyte subpopulations in NZB mice: deficit of thymus-dependent lymphocytes.

Authors:  O Stutman
Journal:  J Immunol       Date:  1972-09       Impact factor: 5.422

5.  Cold-reactive rheumatoid factors in infectious mononucleosis and other diseases.

Authors:  J D Capra; R J Winchester; H G Kunkel
Journal:  Arthritis Rheum       Date:  1969-04

6.  Cytotoxins in disease. Autocytotoxins in lupus.

Authors:  P I Terasaki; V D Mottironi; E V Barnett
Journal:  N Engl J Med       Date:  1970-10-01       Impact factor: 91.245

7.  Lymphocyte cytotoxic antibodies in systemic lupus erythematosus.

Authors:  K K Mittal; R D Rossen; J T Sharp; M D Lidsky; W T Butler
Journal:  Nature       Date:  1970-03-28       Impact factor: 49.962

8.  Antibodies against cell membrane constituents in systemic lupus erythematosus and related diseases. I. Cytotoxic effect of serum from patients with systemic lupus erythematosus (SLE) for allogeneic and for autologous lymphocytes.

Authors:  P Stastny; M Ziff
Journal:  Clin Exp Immunol       Date:  1971-04       Impact factor: 4.330

9.  Occurrence of -globulin complexes in serum and joint fluid of rheumatoid arthritis patients: use of monoclonal rheumatoid factors as reagents for their demonstration.

Authors:  R J Winchester; H G Kunkel; V Agnello
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

10.  Interaction of aggregated -globulin with B lymphocytes.

Authors:  H B Dickler; H G Kunkel
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

View more
  52 in total

1.  Editorial: Lymphocyte subpopulations in chronic inflammatory diseases.

Authors: 
Journal:  Br Med J       Date:  1975-04-05

2.  Antibodies for T lymphocytes in systemic lupus erythematosus.

Authors:  G Michlmayr; C Pathouli; C Huber; H Huber
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330

3.  Effect of ageing on surface IgG of human peripheral lymphocytes.

Authors:  C Zanussi; C Rugarli; B Perussia; R S Smeraldi
Journal:  Experientia       Date:  1977-06-15

4.  Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells.

Authors:  T Sakane; A D Steinberg; J P Reeves; I Green
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

5.  Immune status in Crohn's disease. 3. Peripheral blood B lymphocytes, enumerated by means of F(ab)2-antibody fragments, Null and T lymphocytes.

Authors:  I O Auer; S Götz; E Ziemer; H Malchow; H Ehms
Journal:  Gut       Date:  1979-04       Impact factor: 23.059

6.  Viruses and lymphocytes in rheumatoid arthritis. I. Studies on cultured rheumatoid lymphocytes.

Authors:  M Norval; H Hart; B P Marmion
Journal:  Ann Rheum Dis       Date:  1979-12       Impact factor: 19.103

7.  Fractionation of cells on a discontinuous Ficoll gradient. Study of subpopulations of human T cells using anti-T-cell antibodies from patients with systemic lupus erythematosus.

Authors:  W Glinski; M E Gershwin; A D Steinberg
Journal:  J Clin Invest       Date:  1976-03       Impact factor: 14.808

8.  Brain-reactive lymphocytotoxic antibodies in the serum of patients with systemic lupus erythematosus.

Authors:  H G Bluestein; N J Zvaifler
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

9.  Autoantibodies against Tmu and B lymphocytes in patients with rheumatoid arthritis.

Authors:  C J Meijer; J Cnossen; G J Lafeber; M J Damsteeg; A Cats
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

10.  Stimulation of human monocytes by anti-CD3 monoclonal antibody: induction of inflammatory mediator release via immobilization of Fc receptor by adsorbed immunoglobulin and T-lymphocytes.

Authors:  T Hoffman; A K Tripathi; Y L Lee; E F Lizzio; E Bonvini
Journal:  Inflammation       Date:  1992-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.